aTyr Pharma (LIFE)
(Delayed Data from NSDQ)
$1.57 USD
-0.03 (-1.57%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.57 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Earnings News For LIFE
-
Atyr Pharma: Q4 Earnings Snapshot
-
Atyr Pharma: Q3 Earnings Snapshot
-
Atyr Pharma (LIFE) Reports Q2 Loss, Lags Revenue Estimates
-
Atyr Pharma: Q2 Earnings Snapshot
-
Atyr Pharma (LIFE) Reports Q1 Loss, Misses Revenue Estimates
-
Atyr Pharma: Q1 Earnings Snapshot
-
Atyr Pharma: Q4 Earnings Snapshot
-
Atyr Pharma (LIFE) Reports Q4 Loss, Tops Revenue Estimates
-
Atyr Pharma (LIFE) Reports Q3 Loss, Lags Revenue Estimates
-
Atyr Pharma: Q3 Earnings Snapshot
-
Atyr Pharma: Q2 Earnings Snapshot
-
Atyr Pharma (LIFE) Reports Q1 Loss, Misses Revenue Estimates
-
Atyr Pharma (LIFE) Reports Q3 Loss, Misses Revenue Estimates
-
Atyr Pharma (LIFE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
Atyr Pharma (LIFE) Reports Q2 Loss, Lags Revenue Estimates
-
Atyr Pharma (LIFE) Reports Q1 Loss, Lags Revenue Estimates
-
Analysts Estimate Atyr Pharma (LIFE) to Report a Decline in Earnings: What to Look Out for
-
Atyr Pharma (LIFE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
Atyr Pharma (LIFE) Reports Q2 Loss, Misses Revenue Estimates
-
Atyr Pharma (LIFE) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
-
Atyr Pharma (LIFE) Q1 Earnings and Revenues Surpass Estimates
-
Atyr Pharma (LIFE) Reports Q4 Loss, Beats Revenue Estimates (Revised)
-
Atyr Pharma (LIFE) Reports Q4 Loss, Lags Revenue Estimates
-
TMO's Earnings Beat, LIFE Buyout on Track